Alaunos Therapeutics: Neoplasms trials

The registry lists 10 Neoplasms studies with Alaunos Therapeutics as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesCompletedNCT01242072Phase 1
• Study of Oral Darinaparsin in Patients With Advanced Solid TumorsCompletedNCT01139346Phase 1
• Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsTerminatedNCT00726687Phase 1
• Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and LymphomasCompletedNCT00592163Phase 1
• Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's LymphomasCompletedNCT00591422Phase 1
• A Phase I Trial of ZIO-101 in Solid TumorsCompletedNCT00591396Phase 1
• Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid TumorsCompletedNCT00591383Phase 1
• Phase I Study in Advanced Solid TumorsCompletedNCT00591292Phase 1
• Phase I Study of Indibulin in Patients With Solid TumorsCompletedNCT00591136Phase 1
• A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced CancerCompletedNCT00421135Phase 1